In an era of health reform: defining cost differences in current esophageal cancer management strategies and assessing the cost of complications. [electronic resource]
- The Journal of thoracic and cardiovascular surgery Jan 2011
- 16-21 p. digital
Aged Antineoplastic Agents--adverse effects Chemotherapy, Adjuvant--economics Cost Savings Cost-Benefit Analysis Drug Costs Esophageal Neoplasms--diagnosis Esophagectomy--adverse effects Female Health Care Costs Health Care Reform--economics Health Services Research Hospital Costs Humans Male Middle Aged Models, Economic Neoadjuvant Therapy--economics Outcome and Process Assessment, Health Care--economics Postoperative Complications--economics Radiation Injuries--economics Radiotherapy, Adjuvant--economics Registries Retrospective Studies Time Factors Treatment Outcome Wisconsin